drugset / Trial / NCT01015703

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

NCT01015703 ↗

Phase 1 Completed 50 enrolled BTG International Inc.
NaSingle-groupOpen-labelBasic science

Summary

The study is being conducted to explore the safety and tolerability of CoVaccine HT in healthy male and female volunteers. In this study volunteers will receive intramuscular injections of CoVaccine HT.

Timeline

Start
2009-11
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CoVaccine HT Unknown — Intramuscular

Indications

No indication recorded.